VALSECCHI MARIA GRAZIA

Posizione organizzativa: 
Ruolo: 
professore ordinario
Settore scientifico disciplinare: 
STATISTICA MEDICA (MED/01)
Telefono: 
0264488160
0264488018
Stanza: 
U08, Piano: PT, Stanza: T021
Via Cadore, 48 - 20900 MONZA
U28, Piano: PT, Stanza: T008
Via Follerau, SN - 20854 VEDANO AL LAMBRO

Biografia

Didattica

Pubblicazioni

  • Alberti, P., Rossi, E., Argyriou, A., Kalofonos, H., Briani, C., Cacciavillani, M., et al. (In corso di stampa). RISK STRATIFICATION OF OXALIPLATIN INDUCED PERIPHERAL NEUROTOXICITY APPLYING ELECTROPHYSIOLOGICAL TESTING OF DORSAL SURAL NERVE. SUPPORTIVE CARE IN CANCER. Dettaglio
  • Zamboni, P., Tesio, L., Galimberti, S., Massacesi, L., Salvi, F., D'Alessandro, R., et al. (2018). Efficacy and Safety of Extracranial Vein Angioplasty in Multiple Sclerosis: A Randomized Clinical Trial. JAMA NEUROLOGY, 75(1), 35-43. Dettaglio
  • Pötschger, U., Heinzl, H., Valsecchi, M., & Mittlböck, M. (2018). Assessing the effect of a partly unobserved, exogenous, binary time-dependent covariate on survival probabilities using generalised pseudo-values. BMC MEDICAL RESEARCH METHODOLOGY, 18. Dettaglio
  • Schrappe, M., Bleckmann, K., Zimmermann, M., Biondi, A., Möricke, A., Locatelli, F., et al. (2018). Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000). JOURNAL OF CLINICAL ONCOLOGY, 36(3), 244-253. Dettaglio
  • Cazzaniga, G., De Lorenzo, P., Alten, J., Röttgers, S., Hancock, J., Saha, V., et al. (2018). Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies. HAEMATOLOGICA, 103(1), 107-115. Dettaglio